Lena has installed a system into the GMP facilities at R5. Lena will continue to provide early formulation development services associated with the unit, with subsequent GMP manufacture (and any other downstream processing) carried out at R5. R5 is a contract pharmaceutical development company providing services to companies requiring clinical materials for Phases 1 and 2. It is licensed by MHRA and operates from laboratories in Nottingham, UK